reported that SIRT1 activation promoted ACE2 self-renewal and differentiation in patients with idiopathic pulmonary fibrosis (IPF) and aged mice by regulating the zinc transporter protein SLC39A8 (ZIP8), thereby attenuating pulmonary fibrosis (69). Here, ACE2 is linked to idiopathic pulmonary fibrosis.